Impact of the U.S. blockade on pharmaceutical production in Cuba
To learn about the national production of medicines at the end of 2021 and the behavior in the month of January, Granma newspaper talked to Dr. Eduardo Martinez Diaz, president of the business group of the Biotechnological and Pharmaceutical Industries of Cuba, BioCubaFarma.
We think that as from June, we could start to see improvements in the overall supply of medicines and other products, especially those of higher priority, such as control cards, the executive stated.




